Reference Source

Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.

0009-3073-03 · Methylprednisolone Acetate Injection · Pfizer Inc.

What is the package ndc for 0009-3073-03 · Methylprednisolone Acetate Injection · Pfizer Inc.?

For 0009-3073-03 · Methylprednisolone Acetate Injection · Pfizer Inc., package ndc is 0009-3073-03; generic name is Methylprednisolone Acetate Injection; manufacturer is Pfizer Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

"initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay"

api.fda.gov, retrieved 2026-09-01

Package NDC
0009-3073-03 verified
Generic name
Methylprednisolone Acetate Injection verified
Manufacturer
Pfizer Inc. verified
Status
Current verified
Availability now
Limited Availability verified
FDA note
Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay verified
Initial posting date
12/15/2021 verified
Last update date
08/24/2026 verified
Days in shortage
1721 our reading
Reason for shortage
Other verified
Dosage form
Injection verified
Therapeutic category
Rheumatology verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)", "company_name": "Pfizer Inc.", "shortage_reason": "Other", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.